Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?


OverviewForecastFinancialsChartTranscripts

Atea Pharmaceuticals Ownership Summary


Atea Pharmaceuticals is owned by 19.68% institutional investors, 13.39% insiders, and 66.93% retail investors. Fmr is the largest institutional shareholder, holding 15.16% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 8.18% of its assets in Atea Pharmaceuticals shares.

AVIR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtea Pharmaceuticals19.68%13.39%66.93%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr12.00M15.16%$55.82M
Blackrock funding, inc. /de8.72M11.01%$40.55M
Blackrock9.12M10.87%$30.19M
Bml capital management6.95M8.78%$32.33M
Tang capital management4.81M6.08%$22.39M
Vanguard group4.23M5.35%$15.09M
Vanguard capital management2.96M3.74%$13.79M
Bain capital life sciences investors2.08M2.62%$9.65M
Acadian asset management2.04M2.57%$9.46M
Geode capital management1.96M2.47%$9.11M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management6.95M18.36%$32.33M
Rosalind advisors1.07M1.85%$4.98M
Cm management355.00K1.05%$1.65M
Tang capital management4.81M1.02%$22.39M
Bain capital life sciences investors2.08M0.57%$9.65M
Aldebaran capital88.18K0.31%$410.04K
Auour investments177.00K0.24%$823.05K
Rangeley capital43.50K0.18%$202.28K
Newtyn management492.28K0.17%$1.43M
Spark investment management16.20K0.15%$75.33K

Top Buyers

HolderShares% AssetsChange
Curated wealth partners695.00K0.09%695.00K
Sixth street partners management company610.61K0.00%610.61K
Acadian asset management2.04M0.01%452.38K
Blackrock funding, inc. /de8.72M0.00%284.64K
Quantinno capital management lp242.30K0.00%226.35K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---3.34M
Vanguard group4.23M0.00%-482.17K
Almitas capital---445.39K
Jane street group---418.30K
Two sigma investments, lp1.51M0.01%-357.47K

New Positions

HolderShares% AssetsChangeValue
Curated wealth partners695.00K0.09%695.00K$670.67K
Sixth street partners management company610.61K0.00%610.61K$2.84M
Cubist systematic strategies87.77K0.00%87.77K$254.54K
Algert global38.52K0.00%38.52K$179.12K
Mercer global advisors inc /adv27.86K0.00%27.86K$129.55K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-15.00
Federation des caisses desjardins du quebec-24.00
Capital performance advisors llp-31.00
Colonial trust advisors-46.00
Us bancorp \de\-64.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202656-49.55%16,040,191-71.86%190.38%25-39.02%14-67.44%
Dec 31, 202573-37.61%34,651,553-34.79%431.09%24-45.45%29-27.50%
Sep 30, 20251137.62%52,737,5330.09%621.59%41-16.33%4053.85%
Jun 30, 2025104-52,674,2040.85%621.67%4911.36%25-32.43%
Mar 31, 2025104-2.80%52,838,521-6.02%621.40%45-15.09%3822.58%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S6.54M8.18%-
Fidelity Growth Compy Commingled Pl O3.73M4.42%23.40K
Fidelity Growth Company Fund3.10M3.87%-3.83K
Vanguard US Total Market Shares ETF2.36M2.76%-
Vanguard Morn Total Stk Mkt Idx Investor2.03M2.54%-337.15K
Vanguard Total Stock Mkt Idx Inv2.03M2.54%-337.15K
iShares Russell 2000 ETF1.80M2.24%-31.87K
Fidelity Growth Company K61.22M1.53%3.83K
Vanguard Institutional Extnd Mkt Idx Tr864.90K1.08%47.92K
Fidelity Series Growth Company733.90K0.92%-

Recent Insider Transactions


DateNameRoleActivityValue
May 18, 2026Murphy Polly A.-Buy$25.45K
May 18, 2025Murphy Polly A.-Buy$25.45K
Jan 15, 2025BERGER FRANKLIN M-Buy$47.88K
Jan 16, 2025BERGER FRANKLIN M-Buy$33.61K
Jan 16, 2025BERGER FRANKLIN M-Sell$33.61K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2--
2025 Q14-
2024 Q4-1
2024 Q3-3

AVIR Ownership FAQ


Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals shareholders are primarily institutional investors at 19.68%, followed by 13.39% insiders and 66.93% retail investors. The average institutional ownership in Atea Pharmaceuticals's industry, Biotech Stocks , is 35.43%, which Atea Pharmaceuticals falls below.

Who owns the most shares of Atea Pharmaceuticals?

Atea Pharmaceuticals’s largest shareholders are Fmr (12M shares, 15.16%), Blackrock funding, inc. /de (8.72M shares, 11.01%), and Blackrock (9.12M shares, 10.87%). Together, they hold 37.04% of Atea Pharmaceuticals’s total shares outstanding.

Does Blackrock own Atea Pharmaceuticals?

Yes, BlackRock owns 10.87% of Atea Pharmaceuticals, totaling 9.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.19M$. In the last quarter, BlackRock decreased its holdings by -123K shares, a -1.33% change.

Who is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 18.36% of its assets in 6.95M Atea Pharmaceuticals shares, valued at 32.33M$.

Who is the top mutual fund holder of Atea Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Atea Pharmaceuticals shares, with 8.18% of its total shares outstanding invested in 6.54M Atea Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools